Inventors:
Lindsey A. Miles - San Diego CA, US
John Yates - San Diego CA, US
Emily I. Chen - Port Jefferson NY, US
Nagyung Baik - San Diego CA, US
Robert J. Parmer - San Diego CA, US
International Classification:
C07K 16/00
US Classification:
5303879, 5303871, 53038822
Abstract:
The invention relates to C9orf46 homolog, a novel murine membrane protein, and its orthologs in human, mouse and all other species, termed Plg-R, or analogs, thereof and the isolation method. The function of this molecule is to bind to plasminogen, plasminogen fragments such as angiostatinand other plasminongen fragments having angiostatic activity, tissue plasminogen activator and Lipoprotein(a). Plasminogen receptors function to modulate cell surface proteolysis and physiological and pathophysiological processes requiring cell migration, including, but not limited to, cell migration during inflammation, tissue remodeling, wound healing, tumor cell invasion and metastasis, skeletal myogenesis, neurite outgrowth. Plasminogen receptors also modulate apoptosis and cell death. The invention also relates to antibodies that inhibit plasminogen, plasminogen fragments such as angiostatinand other plasminongen fragments having angiostatic activity, tissue plasminogen activator or Lipoprotein(a) binding to Plg-Rand/or immunoreact with Plg-R.